603087.SHG Gan & Lee Pharmaceuticals Co Ltd

Healthcare Health Care Equipment & Supplies Shanghai Stock Exchange
72.32 CNY
Close of Nov 5, 2026
51.51 79.99
Market cap
CNY 43.2B
P/E
36.2x
P/B
3.45x
ROE
9.6%
Dividend yield
1.38%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603087.SHG undervalued?

Graham number
Price72.32
Graham value30.72
Premium135.4%

603087.SHG trades 135.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Gan & Lee Pharmaceuticals Co Ltd fundamental analysis

No fundamental analysis for Gan & Lee Pharmaceuticals Co Ltd yet.

Gan & Lee Pharmaceuticals Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Gan & Lee Pharmaceuticals Co Ltd

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the development, production, and commercialization of insulin analogs and medical devices in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro mix 75/25 injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, a mixed protamine human insulin injection. The company also…

Full company profile